Literature DB >> 10971235

The effect of unfiltered coffee on potential biomarkers for colonic cancer risk in healthy volunteers: a randomized trial.

M J Grubben1, C C Van Den Braak, R Broekhuizen, R De Jong, L Van Rijt, E De Ruijter, W H Peters, M B Katan, F M Nagengast.   

Abstract

BACKGROUND: Epidemiologic studies suggest that coffee use might protect against colorectal cancer. Inconsistencies as to the effect of coffee use and colorectal cancer between epidemiologic studies might be related to the type of coffee brew.
OBJECTIVE: We studied the effect of unfiltered coffee consumption on putative biomarkers for colonic cancer risk.
DESIGN: A total of 64 healthy volunteers (31 men and 33 women), with a mean age of 43 +/- 11 years were randomly assigned to two groups in a crossover design, with two intervention periods of 2 weeks separated by a washout period of 8 weeks. Treatments were 1 L of cafetière (French press) coffee daily or no coffee. At the end of each intervention period, fasting blood samples, colorectal biopsies and 48 h faeces were collected.
RESULTS: No effect of coffee on colorectal cell proliferation, assayed by estimating the Proliferating Cell Nuclear Antigen labelling index, was seen. Additionally, no effects were seen on the concentrations of faecal soluble bile acids and colorectal mucosal glutathione S-transferase activity. However, unfiltered coffee significantly increased the glutathione content in the colorectal mucosa by 8% and in plasma by 15%. Other aminothiols in plasma also increased on coffee.
CONCLUSION: Unfiltered coffee does not influence the colorectal mucosal proliferation rate, but might increase the detoxification capacity and anti-mutagenic properties in the colorectal mucosa through an increase in glutathione concentration. Whether this effect indeed contributes to a lower colon cancer risk remains to be established.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971235     DOI: 10.1046/j.1365-2036.2000.00826.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Natural products and colon cancer: current status and future prospects.

Authors:  Subapriya Rajamanickam; Rajesh Agarwal
Journal:  Drug Dev Res       Date:  2008-11-01       Impact factor: 4.360

2.  Coffee intake and risk of colorectal cancer among Chinese in Singapore: the Singapore Chinese Health Study.

Authors:  Sabrina Peterson; Jian-Min Yuan; Woon-Puay Koh; Can-Lan Sun; Renwei Wang; Robert J Turesky; Mimi C Yu
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

3.  A Thyroid Hormone-Independent Molecular Fingerprint of 3,5-Diiodothyronine Suggests a Strong Relationship with Coffee Metabolism in Humans.

Authors:  Maik Pietzner; Josef Köhrle; Ina Lehmphul; Kathrin Budde; Gabi Kastenmüller; Georg Brabant; Henry Völzke; Anna Artati; Jerzy Adamski; Uwe Völker; Matthias Nauck; Nele Friedrich; Georg Homuth
Journal:  Thyroid       Date:  2019-11-11       Impact factor: 6.568

Review 4.  Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain-Gut Axis.

Authors:  Amaia Iriondo-DeHond; José Antonio Uranga; Maria Dolores Del Castillo; Raquel Abalo
Journal:  Nutrients       Date:  2020-12-29       Impact factor: 5.717

5.  Association between Coffee Consumption/Physical Exercise and Gastric, Hepatic, Colon, Breast, Uterine Cervix, Lung, Thyroid, Prostate, and Bladder Cancer.

Authors:  So Young Kim; Dae Myoung Yoo; Chanyang Min; Hyo Geun Choi
Journal:  Nutrients       Date:  2021-11-02       Impact factor: 5.717

Review 6.  Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid.

Authors:  Sumio Hayakawa; Tomokazu Ohishi; Noriyuki Miyoshi; Yumiko Oishi; Yoriyuki Nakamura; Mamoru Isemura
Journal:  Molecules       Date:  2020-10-05       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.